Abstract

Using finite element method, this paper evaluates damage in an arterial wall and plaque caused by percutaneous coronary intervention. Hyperelastic damage models, calibrated with experimental results, are used to describe stress–stretch responses of arterial layers and plaque; these models are capable to simulate softening behaviour of the tissue due to damage. Abaqus CAE is employed to create the finite element models for the artery wall (with media and adventitia layers), a symmetric uniform plaque, a bioresorbable polymeric stent and a tri-folded expansion balloon. The effect of percutaneous coronary intervention on vessel damage is investigated by simulating the processes of vessel pre-dilation, stent deployment and post-stenting dilation. Energy dissipation density is used to assess the extent of damage in the tissue. Softening of the plaque and the artery, due to the pre-dilation-induced damage, can facilitate the subsequent stent deployment process. The plaque and the artery experienced heterogeneous damage behaviour after the stent deployment, caused by non-uniform deformation. The post-stenting dilation was effective to achieve a full expansion of the stent, but caused additional damage to the artery. The continuous and discontinuous damage models yielded similar results in the percutaneous coronary intervention simulations, while the incorporation of plaque rupture affected the simulated outcomes of stent deployment. The computational evaluation of the artery damage can be potentially used to assess the risk of in-stent restenosis after percutaneous coronary intervention.

Highlights

  • Percutaneous coronary intervention (PCI) is a prevalent treatment of atherosclerosis to restore a normal blood flow in a coronary artery

  • The damage of the plaque depended on the peak lumen diameter achieved during pre-dilation, and further damage only occurred when the previous peak lumen diameter was exceeded, while the damage of the media and the adventitia always increased with the increasing lumen diameter, even when the peak lumen diameter achieved during the stenting was less than that in the pre-dilation

  • The ABSORB has been removed from the market due to acute scaffold thrombosis concerns, polymeric stents still represent the cutting edge development of generation Bioresorbable Vascular Scaffold (BVS)

Read more

Summary

Introduction

Percutaneous coronary intervention (PCI) is a prevalent treatment of atherosclerosis to restore a normal blood flow in a coronary artery In this stenting procedure, a balloon is generally used to inflate a stent, positioned in the diseased part of the artery, to open the blocked blood vessel. Bare-metal stents were first developed to treat acute vessel occlusions associated with plain balloon angioplasty but can cause a high ISR rate of 20–30% (Foerst et al 2013; Iqbal et al 2013). To overcome this problem, drug-eluting stents were developed and proved effective in battling restenosis by inhibiting neointimal hyperplasia due to proliferation of smooth muscle cells. To eliminate the potential drawbacks of metal stents, bioresorbable vascular

Objectives
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.